Medicrea receives seven US patents for UNiD spinal AI platform

15060
Medicrea
Medicrea’s technology platform

Medicrea has announced that the US Patent Office has recently issued the company seven additional patents related to the UNiD ASI proprietary technology platform.

The company’s proprietary UNiD ASI technology is powered by artificial intelligence (AI) and is designed to enhance clinical and surgical workflow, increase reproducibility, improve surgical outcomes and expand surgeons’ potential.

Medicrea’s UNiD ASI software platform and UNiD LAB expert concierge services enable the surgeon to plan cases pre-operatively, the company said in a press release. The AI embedded within the platform allows a surgeon to visualise the compensatory mechanisms above and below the instrumented spine that will most likely occur based on the suggested surgical plan.

The company continues to actively develop IP protection for these innovations through an aggressive patent strategy, resulting in an IP portfolio that now includes 13 US issued patents as well as others throughout the world.

The seven newly issued patents (US Patent No 10,441,363; 10,433,912; 10,420,615; 10,433,913; 10,426,553; 10,413,365; 10,456,211) are directed to fundamental technologies and methods embedded in the UNiD ASI platform. These additional patent grants enable the company to further expand its existing patent portfolio as it continues to reinforce robust IP protections around its unique technologies for maintaining its position in the space of personalised spine surgery.

Denys Sournac, chief executive officer and founder of Medicrea, said: “Through rigorous and centralised processes, Medicrea permanently improves the content of its clinical database with each new case, allowing our proprietary technology to continuously refine the algorithms behind its predictive model. With over 5,000 cases performed through the UNiD ASI technology platform, all including patient-specific implants, this technology undoubtably met a market need. The new US patents issued create strong barriers to entry for competitors. It enables the company to maintain its competitive advantage and strengthen its leading position in the marketplace that is now obviously evolving into this direction.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here